open access

Vol 3, No 3 (2018)
Original article
Published online: 2018-11-02
Get Citation

Evaluation of protein fractions in the serum as potential determinants of risk of the recurrent miscarriages

Karina Chmielarz1, Lena Nowak-Łoś1
·
Medical Research Journal 2018;3(3):142-147.
Affiliations
  1. Department of Laboratory Medicine, Nicolaus Copernicus University, Collegium Medicum, 9 Sklodowskiej-Curie Street, 85–094 Bydgoszcz, Poland

open access

Vol 3, No 3 (2018)
ORIGINAL ARTICLES
Published online: 2018-11-02

Abstract

Background: According to the World Health Organization, recurrent miscarriage is defined as the loss of 3 or
more consecutive early pregnancies, affecting 0.5% to 3% of pregnant women. According to clinical practice,
it is recommended to perform a diagnostic investigation after two consecutive miscarriages in order to
identify the reason for miscarriages. Despite numerous investigations, around 40–60% of recurrent pregnancy
losses is still idiopathic. In the conducted research, the utility of the determination of serum protein
fractions in the diagnosis of recurrent miscarriage was evaluated.


Material and methods: The study group consisted of 20 women (aged 36.12 ± 3.53) with recurrent miscarriage
of undetermined aetiology. The control group comprised 20 non-pregnant women (aged 35.7 ± 3.28) who
had given birth to healthy children at least twice. Blood serum collected by venipuncture was examined.
Serum protein fractions were separated by electrophoresis in the SDS PAGE buffer system using a Mini
PROTEAN 3 cell device. BioRad SDS PAGE Molecular Weight Standards covering a mass range of 6.5–200
kDa were used as a reference.


Results: Electrophoretic separation revealed 71 protein fractions of 10 to 240 kDa. It was observed that protein
fractions with molecular weights of 27, 36, 53 and 172 kDa were present more frequently in serum from
women in the control group. Protein fractions of 28, 132 and 188 kDa predominated among patients in the
experimental group. This research has demonstrated that the number of 53 and 172 kDa protein fractions
decreased with the number of miscarriages.


Conclusions: It is suggested that individual protein fractions may increase the risk of a miscarriage.

Abstract

Background: According to the World Health Organization, recurrent miscarriage is defined as the loss of 3 or
more consecutive early pregnancies, affecting 0.5% to 3% of pregnant women. According to clinical practice,
it is recommended to perform a diagnostic investigation after two consecutive miscarriages in order to
identify the reason for miscarriages. Despite numerous investigations, around 40–60% of recurrent pregnancy
losses is still idiopathic. In the conducted research, the utility of the determination of serum protein
fractions in the diagnosis of recurrent miscarriage was evaluated.


Material and methods: The study group consisted of 20 women (aged 36.12 ± 3.53) with recurrent miscarriage
of undetermined aetiology. The control group comprised 20 non-pregnant women (aged 35.7 ± 3.28) who
had given birth to healthy children at least twice. Blood serum collected by venipuncture was examined.
Serum protein fractions were separated by electrophoresis in the SDS PAGE buffer system using a Mini
PROTEAN 3 cell device. BioRad SDS PAGE Molecular Weight Standards covering a mass range of 6.5–200
kDa were used as a reference.


Results: Electrophoretic separation revealed 71 protein fractions of 10 to 240 kDa. It was observed that protein
fractions with molecular weights of 27, 36, 53 and 172 kDa were present more frequently in serum from
women in the control group. Protein fractions of 28, 132 and 188 kDa predominated among patients in the
experimental group. This research has demonstrated that the number of 53 and 172 kDa protein fractions
decreased with the number of miscarriages.


Conclusions: It is suggested that individual protein fractions may increase the risk of a miscarriage.

Get Citation

Keywords

recurrent miscarriage, protein fractions, abortion, pregnancy, electrophoresis

Supp./Additional Files (1)
Tables
Download
59KB
About this article
Title

Evaluation of protein fractions in the serum as potential determinants of risk of the recurrent miscarriages

Journal

Medical Research Journal

Issue

Vol 3, No 3 (2018)

Article type

Original article

Pages

142-147

Published online

2018-11-02

Page views

795

Article views/downloads

707

DOI

10.5603/MRJ.a2018.0024

Bibliographic record

Medical Research Journal 2018;3(3):142-147.

Keywords

recurrent miscarriage
protein fractions
abortion
pregnancy
electrophoresis

Authors

Karina Chmielarz
Lena Nowak-Łoś

References (8)
  1. Diejomaoh MFE. Recurrent spontaneous miscarriage is still a challenging diagnostic and therapeutic quagmire. Med Princ Pract. 2015; 24 Suppl 1: 38–55.
  2. Rekomendacje Polskiego Towarzystwa Ginekologicznego w zakresie wybranych patologii wczesnej ciąży oraz postępowania w ciąży po zapłodnieniu in vitro. Prz Menopauz, 2004; 6. ; 8: 8–12.
  3. Bręborowicz GH, Urban J, Skrzypczak J, et al. Położnictwo i ginekologia. Red. Wydawnictwo Lekarskie PZWL, Warszawa 2014; 1: 85-91. : 160–162.
  4. Lewicka M, Sulima M, Pyć M, et al. Charakterystyka poronień i prawa przysługujące kobiecie po stracie ciąży. Annales Academiae Medicae Stetinensis – Roczniki Pomorskiej Akademii Medycznej w Szczecinie, 2013; 59. ; 1: 123–129.
  5. Malinowski A, Radwan M. Diagnostyka immunologiczna w poronieniach nawykowych: algorytm postępowania diagnostyczno-leczniczego z wykorzystaniem wyników badań własnych, Perinatol Neonatol Ginekol. 2011; 4. ; 4: 27–36.
  6. Pereza N, Ostojić S, Smirčić A, et al. The -2549 insertion/deletion polymorphism in the promoter region of the VEGFA gene in couples with idiopathic recurrent spontaneous abortion. J Assist Reprod Genet. 2015; 32(12): 1789–1794.
  7. Nagirnaja L, Palta P, Kasak L, et al. Structural genomic variation as risk factor for idiopathic recurrent miscarriage. Hum Mutat. 2014; 35(8): 972–982.
  8. Kim MS, Gu BH, Song S, et al. ITI-H4, as a biomarker in the serum of recurrent pregnancy loss (RPL) patients. Mol Biosyst. 2011; 7(5): 1430–1440.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl